White Coat Quarterly

NAV CANADA signs on for another five years of support for cancer research

The Ottawa Hospital Foundation is thankful for the ongoing support of NAV CANADA who has raised an incredible $1,350,000 in the past five years in support of cancer care and research. The extraordinary generosity of NAV CANADA’s employees shows no limits, as the company announced their commitment to an additional five years of support.

“I’m pleased to announce that NAV CANADA will be partnering with the Ottawa Hospital Foundation for another five years,” said John Crichton, President and CEO of NAV CANADA. “I know that our employees will rise to the challenge, as they do every day in helping keep our skies safe and aircraft moving efficiently. This is yet another example of their generosity and community spirit, so much in evidence in communities across the country in which they live and work.”

The employees of NAV CANADA have enthusiastically supported the ground-breaking cancer research led by Dr. John Bell, which has allowed for tremendous advancements in cancer care. Recently, NAV CANADA launched their 2013 “Renewed Hope” Fundraising Campaign, which will continue to support Dr. Bell’s research team, and specifically Dr. Rebecca Auer’s recent study of cancer vaccines.

Thank you NAV CANADA for making a significant impact on cancer care in our community.

Dr. Jean-Simon Diallo provided updates on his oncolytic virus research, as well as the work of Drs. John Bell and Rebecca Auer at the Leadership Breakfast on May 28.

Dr. Kelley Parato shared details about Drs. John Bell and Rebecca Auer’s recent cancer vaccine research developments. Left to right: John Crichton, President & CEO, NAV CANADA; Tim Kluke, President & CEO, TOHF; Kelley Parato, OHRI; Charles Lapointe, VP,
Technical Operations, NAV CANADA 

White Coat Quarterly